Dosidal · Belgium

Theracap 37 MBq - 5550 MBq

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketBelgium
Recordbe:presentation:cti:334266-09 (version 1)
Levelpresentation
Pack codebe-cnk (Belgian national): 3330438
Identifiersbe-cti-extended: 334266-09
be-cnk: 3330438
be-authorisation: BE334266
Source authorityFAMHP
Read date2026-11-15T03:58:09Z
authorisation statusamp_status: REVOKED
ampp_status: REVOKED
commercialised_now: False
lifecycle: history
period_from: 2025-11-11
supply_problem_now: False
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
controlled status
state: unknown
identityamp_code: SAM334266-00
atc: V10XA01
authorisation_number: BE334266
cti_extended: 334266-09
form: Capsule, hard
holder: GE Healthcare
medicine_type: ALLOPATHIC
name: Theracap 37 MBq - 5550 MBq
pack: 1 (333 MBq)
parallel_circuit: 0
parallel_import: False
substances: substance: Sodium Iodide (131 I)
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
pack product codecnk_public: 3330438
fmd_in_scope: False
note: no FMD product code in SAM for this pack: the maker's GTIN is not published
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
prescription classas_published: Restricted medical prescription H - Art 6, §1 bis, 2nd paragraph, 4th indent and 7th paragraph, 4) Law 25/03/1964 + Art 63 Royal Decree 14/12/2006 Delivery in hospital pharmacy
class: prescription
delivery_modus: M44
specification: H
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
Zols7SUSyZ4fxzdQmybV5NKQwA4Y9vqND7nafJPFZB1zI4Muo7lrGiGUFpXkuwnYS7FeCSXUOOy10CBXCYJJ2Q
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/be:presentation:cti:334266-09 · Related records in other markets · Dosidal